Find out more about David Prior's experience
David Prior's highlights
FEATURED Journal article
Poor Survival with Impaired Valvular Hemodynamics After Aortic Valve Replacement: The National Echo Database Australia Study
Read moreDavid Prior's selected work
A MULTI-CENTRE DOUBLE-BLIND RANDOMISED PLACEBO-CONTROLLED TRIAL OF ORAL ANTICOAGULATION IN..
Research Grant
Incremental prognostic value of echocardiography of left ventricular remodeling and diasto..
Journal article
PULMONARY MICROVASCULAR PATHOLOGY AS A CAUSE OF EXERCISE LIMITATION IN DIABETICS: IDENTIFI..
Research Grant
The Effect of Transitional Care on 30-Day Outcomes in Patients Hospitalised With Acute Hea..
Journal article
SALARY CONTRIBUTION DAVID PRIOR 19/22
Research Contracts
Age-related longitudinal change in cardiac structure and function in adults at increased c..
Journal article
David Prior's selected work
Projects
Displaying the 4 most recent projects by David Prior.
Project Types
2
Research Contracts
2
Research Grant
Additional Information
The Cleveland Clinic Foundation Research Grants Committee. Prognostic value of color M-mode and tissue Doppler imaging to assess diastolic function in congestive heart failure due to impaired left ventricular systolic function. David Prior, Allan Klein, Randall Starling, Michelle Deguise, Jeremy Pereira. 2000, 1 year, $26,000.
St Vincent’s Hospital Research Endowment Fund. Prediction of responses to beta-blocker therapy in heart failure using Doppler filling patterns of the left ventricle. David Prior, Andrew MacIsaac. 2001, 1 year, $8,000.
National Heart Foundation of Australia. Amino-terminal pro-brain natriuretic (NT-proBNP) and heart disease: Evaluation of the utility of NT-proBNP in the diagnosis of “early” heart failure. DJ Campbell, AI MacIsaac, DL Prior. 2001 & 2002, $35,000 per annum.
Sylvia & Charles Viertel Clinical Investigatorship. Value of NT pro-BNP assay for diagnosis of heart failure and the role of echocardiographic assessment of diastolic function in predicting response to beta-blockade in heart failure. David Prior 2002, $55,000.
CVL Pfizer Cardiovascular Lipid Research Grant. The role of new and conventional echocardiographic measures of diastolic function in predicting response to beta-blockade and prognosis in heart failure. David Prior Andrew MacIsaac. 2002, $50,000.
National Heart Foundation of Australia. New and conventional echocardiographic measures of diastolic function in predicting response to beta-blockade and prognosis in heart failure. David Prior, Andrew MacIsaac, David Kaye. 2002, $50,000; 2003, $42,735.
National Health and Medical Research Council. Efficacy and mechanisms of exercise training in diastolic heart failure (301136) Thomas Marwick, David Prior, David Hare, Jeff Coombes, Dominic Leung, Brian Haluska. 2004 – 2006, $543,450.
St Vincent’s Hospital Research Endowment Fund. Effect of ultra-endurance exercise on cardiac function assessed by echocardiography. Andre LaGerche, David Prior, Andrew MacIsaac. 2004, 1 year, $5,000.
St Vincent’s Hospital Research Endowment Fund. Non-invasive assessment of exercise haemodynamics in subjects with and without heart failure - validation of E/E ratio and TR-derived RVSP with exercise. Andrew Burns, David Prior, Andrew MacIsaac 2006, 1 year,l
National Heart Foundation of Australia. Investigation of the pathogenesis of diastolic dysfunction. Duncan Campbell, David Prior, Mary Jane Black. 2007 $61,500, 2008 $61,500.
CVL Pfizer Cardiovascular Lipid Research Grant. The role of pro-inflammatory cytokines and neuro-hormones in the aetiology of acute myocardial dysfunction following endurance exercise. Andre La Gerche, David Prior, Warrwick Inder 2008 $55,000.
National Health and Medical Research Council. NT-proBNP and the identification and treatment of structural heart disease and heart failure in high-risk individuals (559010) Duncan Campbell, David Prior, Danny Liew, Rory Wolffe. 2009 – 2013, ,420,375
.
National Heart Foundation of Australia. Assessment of early pulmonary arterial hypertension using dobutamine stress echocardiograms in patients with scleroderma (G 08M 3732). David Prior, Wendy Stevens, Andrew MacIsaac. 2009 - 2010 20,750.
National Heart Foundation of Australia. Effect of diabetes on the heart (G 08M 3833). Duncan Campbell, David Prior, Mary Jane Black. 2009 - 2010.
Arthritis Australia Assessing early pulmonary hypertension in scleroderma David Prior, Wendy Stevens, Andrew MacIsaac. 2009 5,000.
Scholarly Works
Displaying the 10 most recent scholarly works by David Prior.
Keyword Analysis
Honours, Awards and Fellowships
Postgraduate Research Scholarship
Medical Postgraduate Scholarship
Postgraduate Research Scholarship
Medical Postgraduate Scholarship
Travelling Fellowship
Medical Postgraduate Scholarship
Postgraduate Research Scholarship
Postgraduate Research Scholarship
Medical Postgraduate Scholarship
FACC - Fellow of the American College of Cardiology
FCSANZ - Fellow of the Cardiac Society of Australia and New Zealand
FRACP - Fellow of the Royal Australasian College of Physicians
Credentials
Positions
Positions
Associate Professor
Medicine - St Vincent'S Hospital
Member
American College of Cardiology
Member
American Society of Echocardiography
Member
Australasian Society for Ultrasound in Medicine
Member
Cardiac Society of Australia and New Zealand
Registered
Medical Board of Victoria
Education
Education
Doctor of Philosophy
Monash University
Bachelor of Medicine & Bachelor of Surgery
Monash University
Bachelor of Medical Science
Monash University